Boston Sleep Tech Company Ozlo Raises $22 Million
The firm plans to expand its health technology ecosystem following a successful Series B funding round.
Updated on Oct. 29, 2026 in Sleep Disorders
Live Poll
Do you trust wearable technology companies to provide effective solutions for your sleep health?
Boston-based sleep tech company Ozlo has secured $22 million in Series B funding to scale its operations and advance its research. The round was led by Modi Ventures and includes the company's previously issued convertible instruments.
Why it matters
This investment will accelerate the development of new sleep health technologies and support the company's goal of entering additional clinical areas. It marks a significant milestone as the brand seeks to broaden its impact beyond its existing hardware offerings.
Ozlo has surpassed 260,000 customers in under two years of operation. The company's Sleepbuds 2, launched in July 2026, provide 14 hours of battery life per charge.
The players
Ozlo
A Boston-based sleep technology company that designs products aimed at improving nighttime health through audio engineering and noise masking.
Modi Ventures
An investment firm that led the recent Series B funding round for Ozlo.
Dreem Health
A virtual sleep clinic that maintains a partnership with Ozlo to support its clinical sleep health initiatives.
The details
Ozlo utilizes a combination of intelligent noise masking, engineered audio, and specialized hardware design to improve sleep outcomes. The company is currently conducting regulatory work to submit a new tinnitus product to the FDA for review.
Timeline
July 2026: Ozlo launched its Sleepbuds 2 product.
October 29, 2026: The company announced the closing of its Series B funding round.
The Big Picture
Ozlo is aligning its internal product development roadmap with the FDA medical device regulatory pathway as it prepares to commercialize clinical-grade tinnitus solutions. This strategic shift indicates a transition from consumer wellness products to regulated medical technology.
Users can expect the company to introduce new clinical-grade sleep health programs in the future as a result of this research funding. Those interested in current offerings can continue to access the existing Sleepbuds line through the company's established digital channels.
The takeaway
The move into clinical-grade products highlights the growing convergence between wearable technology and medical health services. Consumers should look for future announcements regarding FDA-cleared devices that may offer more targeted relief for specific conditions like tinnitus.
Further reading
For more information on the evolving technology behind managing rest, visit the Boston Sleep Disorders section.
More information
To view current company offerings and research initiatives, visit the Ozlo company information website.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you trust wearable technology companies to provide effective solutions for your sleep health?
